<DOC>
	<DOCNO>NCT00742001</DOCNO>
	<brief_summary>Feasibility trial evaluate recovery survival RBCs Mirasol-treated whole blood</brief_summary>
	<brief_title>Feasibility Study Mirasol-Treated Whole Blood Red Cell Recovery Survival</brief_title>
	<detailed_description>Radiolabeling red blood cell subsequent autologous infusion donor commonly use surrogate evaluate circulation red blood cell vivo . By measure level radioisotope blood sample , test evaluate percentage red blood cell remain bloodstream 24 hour ( recovery ) predict long red blood cell remain circulation ( survival ) . The IMPROVE trial feasibility trial evaluate parameter red blood cell obtain whole blood unit treat Mirasol System .</detailed_description>
	<criteria>healthy adult meet AABB criterion whole blood donation female incapable become pregnant male agree use contraception trial pregnancy nurse abnormal medical history ( bleed disorder , anemia , MI , uncontrolled hypertension , heart disease , epilepsy ) major surgery use drug affect coagulation RBC function recent participation trial may confound result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>red blood cell</keyword>
	<keyword>transfusion</keyword>
	<keyword>recovery</keyword>
	<keyword>feasibility</keyword>
	<keyword>white blood cell inactivation</keyword>
</DOC>